Literature DB >> 8757415

Adjustment of creatinine-adjusted value to urine flow rate in lead workers.

F Sata1, S Araki.   

Abstract

Two male lead workers, aged 57 and 51 y, were studied to compare the urinary flow/creatinine-adjusted values published earlier by Araki et al. and by Greenberg and Levine. We collected 24-h urine samples once a month for 31 mo and 16 mo for workers 1 and 2, respectively. The workers' urinary excretions of lead, delta-aminolevulinic acid, and coproporphyrin were measured. No significant correlations between urine flow rate and urinary flow/creatinine-adjusted values published by Araki et al. for the three substances were found for these two workers. However, urinary flow/creatinine-adjusted values presented by Greenberg and Levine for lead and delta-aminolevulinic acid were correlated positively with urine flow rate in the two workers, and their adjusted value for coproporphyrin was correlated positively with urine flow rate in one of the workers. We concluded that use of the urinary flow/creatinine-adjusted value by Greenberg and Levine for biological monitoring poses a problem because of the theoretical fallacy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8757415     DOI: 10.1080/00039896.1996.9936034

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN: 0003-9896


  4 in total

1.  Investigation of lead concentrations in whole blood, plasma and urine as biomarkers for biological monitoring of lead exposure.

Authors:  Johan Nilsson Sommar; Maria Hedmer; Thomas Lundh; Leif Nilsson; Staffan Skerfving; Ingvar A Bergdahl
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-02-27       Impact factor: 5.563

2.  Creatinine normalization in biological monitoring revisited: the case of 1-hydroxypyrene.

Authors:  C Viau; M Lafontaine; J P Payan
Journal:  Int Arch Occup Environ Health       Date:  2004-02-04       Impact factor: 3.015

3.  Comparison of creatinine and specific gravity for hydration corrections on measurement of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine.

Authors:  Yang Xia; Lee-Yang Wong; Brandon C Bunker; John T Bernert
Journal:  J Clin Lab Anal       Date:  2014-03-19       Impact factor: 2.352

4.  Assessing urinary flow rate, creatinine, osmolality and other hydration adjustment methods for urinary biomonitoring using NHANES arsenic, iodine, lead and cadmium data.

Authors:  Daniel R S Middleton; Michael J Watts; R Murray Lark; Chris J Milne; David A Polya
Journal:  Environ Health       Date:  2016-06-10       Impact factor: 5.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.